Marginal Bone Level Assessment of Additive-Manufactured Titanium Implants at 30 and 90 Days: 1-year non-inferiority within-subject randomized clinical trial

niversidade de São Paulo - Faculdade de Odontologia0 sitesNovember 25, 2022

Overview

Phase: 未知
Intervention: Not specified
Conditions: oss of teeth due to accident, extraction or localized periodontal diseases
Sponsor: niversidade de São Paulo - Faculdade de Odontologia
Status: Not yet recruiting
Last Updated: 2 years ago

No summary available.

Registry

who.int

Start Date

November 25, 2022

End Date

November 1, 2023

Last Updated

2 years ago

Study Type

Intervention

Sponsor

niversidade de São Paulo - Faculdade de Odontologia

•Patients who are a minimum age of 18 years and a maximum of 70 years; with good general health; who have signed the Informed Consent Form; in need of rehabilitation with dental implants in areas of mandible or posterior maxilla (premolars and/or molars); with bacterial plaque index \= 20%; bleeding rate \= 20%; sufficient alveolar bone volume for an implant of 8 or 10mm length, diameter of 3\.5mm, 4\.00mm or 4\.5mm, with bone quality type I\-III and no associated bone regeneration required

•Pregnant and lactating women; uncontrolled diabetes; history of chemotherapy or radiotherapy in the last 5 years; radiation therapy to areas of the head and neck; use of immunosuppressants, bisphosphonates or prolonged use of corticosteroids; smokers; alcohol or drug abuse; untreated periodontitis; history of previous bone augmentate in the implant installation region; presence of residual roots at the site to receive the implant; type IV bone density; individuals with connective tissue disorders or bone metabolic diseases; postmenopausal osteoporosis or other systemic diseases that may affect bone metabolism; need for guided bone regeneration at the time of implant placement